Education
About Us
Working with TipRanks
Follow Us
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
1276 Analyst Ratings
Moderate Buy
4 Buy
2 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1276 Stock 12 Month Forecast
Average Price Target
HK$87.49
▲(20.76% Upside)
| Highest Price TargetHK$108.00 | Average Price TargetHK$87.49 | Lowest Price TargetHK$69.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Unknown Analyst
DaiwaNot Ranked
Daiwa
HK$86→HK$79.5
Sell
9.73%
Upside
Reiterated
10/28/25
Unknown Analyst
BOCOM International Holdings CompanyNot Ranked
BOCOM International Holdings Company
HK$69.5
Hold
-4.07%
Downside
Reiterated
10/28/25
Unknown Analyst
DaiwaNot Ranked
Daiwa
HK$86
Sell
18.70%
Upside
Reiterated
10/13/25
Nomura
HK$94.54
Buy
30.49%
Upside
Reiterated
09/25/25
J.P. Morgan
HK$78
Hold
7.66%
Upside
Initiated
09/23/25
Macquarie
HK$92→HK$98
Buy
35.27%
Upside
Reiterated
09/08/25
Unknown Analyst
Citic SecuritiesNot Ranked
Citic Securities
HK$111
Buy
53.21%
Upside
Reiterated
08/28/25
Citi
HK$134
Buy
84.96%
Upside
Initiated
07/10/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Unknown Analyst
DaiwaNot Ranked
Daiwa
HK$86→HK$79.5
Sell
9.73%
Upside
Reiterated
10/28/25
Unknown Analyst
BOCOM International Holdings CompanyNot Ranked
BOCOM International Holdings Company
HK$69.5
Hold
-4.07%
Downside
Reiterated
10/28/25
Unknown Analyst
DaiwaNot Ranked
Daiwa
HK$86
Sell
18.70%
Upside
Reiterated
10/13/25
Nomura
HK$94.54
Buy
30.49%
Upside
Reiterated
09/25/25
J.P. Morgan
HK$78
Hold
7.66%
Upside
Initiated
09/23/25
Macquarie
HK$92→HK$98
Buy
35.27%
Upside
Reiterated
09/08/25
Unknown Analyst
Citic SecuritiesNot Ranked
Citic Securities
HK$111
Buy
53.21%
Upside
Reiterated
08/28/25
Citi
HK$134
Buy
84.96%
Upside
Initiated
07/10/25
Best Analysts Covering Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
1 Month
xxx
Success Rate
2/2 ratings generated profit
Average Return
+8.50%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +8.50% per trade.
3 Months
xxx
Success Rate
1/2 ratings generated profit
Average Return
-3.20%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -3.20% per trade.
1 Year
2 Years
xxx
Success Rate
1/2 ratings generated profit
Average Return
-1.75%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -1.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
1276 Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
2
2
1
1
1
Buy
3
9
8
7
2
Hold
1
2
2
2
1
Sell
0
0
2
2
2
Strong Sell
0
0
0
0
0
total
6
13
13
12
6
Each month's total comprises the sum of three months' worth of ratings.
1276 Financial Forecast
1276 Stock Forecast FAQ
What is HK:1276’s average 12-month price target, according to analysts?
Based on analyst ratings, Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s 12-month average price target is 87.49.
What is HK:1276’s upside potential, based on the analysts’ average price target?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has 20.76% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H a Buy, Sell or Hold?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 2 hold ratings and 1 sell ratings.
What is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s share price target?
The average share price target for Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H is 87.49. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$108.00 ,and the lowest forecast is HK$69.50. The average share price target represents 20.76% Increase from the current price of HK$72.45.
The highest analyst share price target is HK$108.00 ,and the lowest forecast is HK$69.50. The average share price target represents 20.76% Increase from the current price of HK$72.45.
What do analysts say about Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H?
To buy shares of HK:1276, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.